Clinical Trial: A Phase III Study of A01016 in Subjects With Symptomatic Vitreomacular Adhesion

Study Status: Completed
Recruit Status: Completed
Study Type: Interventional




Official Title: A Phase III Study of A01016 125μg Intravitreal Injection in Subjects With Symptomatic Vitreomacular Adhesion - Comparison Study to Sham Injection

Brief Summary: The purpose of this study is to evaluate the superiority regarding vitreomacular adhesion (VMA) resolution of a single intravitreal injection of A01016 (Ocriplasmin) compared to sham-injection in subjects with symptomatic VMA.